A comprehensive view of AbbVie Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Abbvie acquires biotech firm DJS Antibodies for US$255.0M; DJS develops antibody medicines focused on disease-causing proteins, including DJS-002, which is in preclinical studies to treat idiopathic pulmonary fibrosis and other fibrotic diseases

AbbVie's Allergan Aesthetics and Girls Inc. partner for fourth consecutive year to support engagement of high school aged girls interested in STEM; social media campaign will educate on underrepresentation of female and diverse voices in STEM

AbbVie's Allergan Aesthetics, skinbetter science share report from DREAM initiative on inclusive beauty, finding just 17% of women feel their racial beauty is accepted by society; Forces of Beauty initiative will promote diversity in multi-media launch

Executive Perspective: AbbVie CEO predicts pharmacy benefit managers, payers will favor most reliable suppliers when AbbVie loses exclusivity to Humira in 2023; at least six companies plan to launch Humira biosimilars

AbbVie laying off 99 employees at Irvine, California, manufacturing site; Bristol Myers Squibb laying off 262 employees at two sites in San Diego County, California, one of which was part of BMS’ acquisition of Turning Point Therapeutics in August

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count